Jump to content

STXBP5

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Monkbot (talk | contribs) at 22:09, 8 December 2020 (Task 18 (cosmetic): eval 11 templates: del empty params (6×);). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

STXBP5
Identifiers
AliasesSTXBP5, Tomosyn, LGL3, LLGL3, Nbla04300, syntaxin binding protein 5
External IDsOMIM: 604586; MGI: 1926058; HomoloGene: 16402; GeneCards: STXBP5; OMA:STXBP5 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001127715
NM_139244
NM_001394409

NM_001081344
NM_030191

RefSeq (protein)

NP_001121187
NP_640337

NP_001074813
NP_001394992
NP_001394993
NP_001394994

Location (UCSC)Chr 6: 147.2 – 147.39 MbChr 10: 9.76 – 9.9 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Syntaxin-binding protein 5 is a protein that in humans is encoded by the STXBP5 gene. It is also known as tomosyn, after , "friend" in Japanese, for its role as a binding protein.[5][6][7]

Function

Syntaxin 1 is a component of the 7S and 20S SNARE complexes which are involved in docking and fusion of synaptic vesicles with the presynaptic plasma membrane. This gene encodes a syntaxin 1 binding protein. In rat, a similar protein dissociates syntaxin 1 from the Munc18/n-Sec1/rbSec1 complex to form a 10S complex, an intermediate which can be converted to the 7S SNARE complex. Thus this protein is thought to be involved in neurotransmitter release by stimulating SNARE complex formation. Alternatively spliced variants have been identified, but their biological validity has not been determined.[7]

Positional cloning suggested that tomosyn might inhibit neurotransmitter secretion in Caenorhabditis elegans neurons.][8] This hypothesis was tested and confirmed, showing that tomosyn specifically inhibits synaptic vesicle priming—the biochemical step immediately preceding vesicle fusion and neurotransmitter release.[9]

Structure

Two functional domains were originally identified, including one which binds to syntaxin, but recent crystallization of the yeast homolog Sro7 revealed that tomosyn likely has three functional domains: one WD40 domain and one syntaxin-binding domain, as previously recognized, but also another WD40 domain. The study also suggested that tomosyn's 'syntaxin binding domain' is not the reason tomosyn is inhibitory for neurotransmitter release, as originally proposed.[10] The Sro7-based structure is currently given on SWISS-MODEL, which includes the WD40 domains but not most of the coiled coil syntaxin-binding domain seen in the infobox.[11]

Interactions

STXBP5 has been shown to interact with STX4[12] and STX1A.[5][12]

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000164506Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000019790Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ a b Fujita Y, Shirataki H, Sakisaka T, Asakura T, Ohya T, Kotani H, Yokoyama S, Nishioka H, Matsuura Y, Mizoguchi A, Scheller RH, Takai Y (Jun 1998). "Tomosyn: a syntaxin-1-binding protein that forms a novel complex in the neurotransmitter release process". Neuron. 20 (5): 905–15. doi:10.1016/S0896-6273(00)80472-9. PMID 9620695. S2CID 12597505.
  6. ^ Katoh M, Katoh M (Feb 2004). "Identification and characterization of human LLGL4 gene and mouse Llgl4 gene in silico". Int. J. Oncol. 24 (3): 737–42. doi:10.3892/ijo.24.3.737. PMID 14767561.
  7. ^ a b "Entrez Gene: STXBP5 syntaxin binding protein 5 (tomosyn)".
  8. ^ Dybbs M, Ngai J, Kaplan JM (July 2005). "Using microarrays to facilitate positional cloning: identification of tomosyn as an inhibitor of neurosecretion". PLOS Genet. 1 (1): 6–16. doi:10.1371/journal.pgen.0010002. PMC 1183521. PMID 16103915.{{cite journal}}: CS1 maint: unflagged free DOI (link) Open access icon
  9. ^ Gracheva EO, Burdina AO, Holgado AM, et al. (July 2006). "Tomosyn inhibits synaptic vesicle priming in Caenorhabditis elegans". PLOS Biol. 4 (8): e261. doi:10.1371/journal.pbio.0040261. PMC 1514790. PMID 16895441.{{cite journal}}: CS1 maint: unflagged free DOI (link) Open access icon
  10. ^ Hattendorf DA, Andreeva A, Gangar A, Brennwald PJ, Weis WI (March 2007). "Structure of the yeast polarity protein Sro7 reveals a SNARE regulatory mechanism". Nature. 446 (7135): 567–71. Bibcode:2007Natur.446..567H. doi:10.1038/nature05635. PMID 17392788. S2CID 4399611.
  11. ^ "Q5T5C0". SWISS-MODEL Repository.
  12. ^ a b Widberg CH, Bryant NJ, Girotti M, Rea S, James DE (Sep 2003). "Tomosyn interacts with the t-SNAREs syntaxin4 and SNAP23 and plays a role in insulin-stimulated GLUT4 translocation". J. Biol. Chem. 278 (37): 35093–101. doi:10.1074/jbc.M304261200. PMID 12832401.

Further reading